| Date | Form | Description | Docs | XBRL | Pages |
| 09/14/10 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 08/24/10 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/20/10 | 8-K | Current report filing |
|
3 | |
| 07/27/10 | CT ORDER | Confidential treatment order |
|
1 | |
| 07/27/10 | UPLOAD | SEC-generated letter |
|
1 | |
| 07/21/10 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
11 | |
| 07/20/10 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
32 | |
| 07/20/10 | 8-K | Current report filing |
|
41 | |
| 06/29/10 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
5 | |
| 06/29/10 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
81 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...